Poly (ADP-ribose) polymerase-1 (PARP-1) −410C/T polymorphism in Sicilian patients with Parkinson's disease
暂无分享,去创建一个
P. Bosco | M. C. Morale | F. Cosentino | R. Spada | C. Romano | M. Salemi | F. Scillato | M. G. Salluzzo | R. G. Rando | Federica Elia
[1] P. Bosco,et al. Association study of COX-2 (PTGS2) –765 G/C promoter polymorphism by pyrosequencing in Sicilian patients with Alzheimer's disease , 2014, Archives of medical science : AMS.
[2] R. Ataee,et al. Homocysteine Intracerebroventricular Injection Induces Apoptosis in the Substantia Nigra Cells and Parkinson's Disease LikeBehavior in Rats , 2013, International journal of molecular and cellular medicine.
[3] Eric P Kaldjian,et al. Upregulation of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Triple-Negative Breast Cancer and Other Primary Human Tumor Types. , 2010, Genes & cancer.
[4] Jan Petter Larsen,et al. Epidemiology of Parkinson’s disease , 2008, Journal of Neurology.
[5] O. Combarros,et al. Poly (ADP-ribose) polymerase-1 (PARP-1) genetic variants are protective against Parkinson's disease , 2007, Journal of the Neurological Sciences.
[6] T. Dawson,et al. Mediation of cell death by poly(ADP-ribose) polymerase-1. , 2005, Pharmacological research.
[7] M. Moskowitz,et al. Poly(ADP‐ribose) polymerase‐1 activity promotes NF‐κB‐driven transcription and microglial activation: implication for neurodegenerative disorders , 2003, Journal of neurochemistry.
[8] Y. Mizuno,et al. Histochemical detection of apoptosis in Parkinson's disease , 1996, Journal of the Neurological Sciences.
[9] W. Gibb,et al. Accuracy in the clinical diagnosis of parkinsonian syndromes. , 1988, Postgraduate medical journal.